StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) stock

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$84.78+10.38 (+13.95%)

Close on Nov 16, 2026Market cap $7.51BP/E –Yield –

CG Oncology gross margin

Gross margin is gross profit as a percentage of revenue.

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-66.4%–
Q3 FY2025Sep 30, 20255.3%–

More CG Oncology figures

See a number that looks wrong?